Back

The development of small-molecule ERBB4 agonists as a treatment for heart failure

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel targets against myocardial damage Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Julie Cools

University of Antwerp, Antwerp (Belgium)

5 More presentations in this session

Presentation thumbnail
Renal Semaphorin 3C mediates cardiac adaptive response
Mr Y. Otaki (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
Vaccination targeting senescence-associated transmembrane protein alleviated cardiovascular pathology in the mice
Doctor C. Hsiao (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Nap1L1 Ubiquitination Degradation-dependent Protective Effects of Wnt2 on Cardiac Ischemia/Reperfusion Injury
Doctor Y. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
The protective role of Baz2b ablation in aging-related heart failure
Mrs T. Zang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitor empagliflozin prevents anthracycline-induced cardiotoxicity in a large-animal model
Ms D. Medina-Hernandez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Novel targets against myocardial damage
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources